HFS
RPRX icon

Hughes Financial Services’s Royalty Pharma RPRX Stock Holding History

Hughes Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08K Buy
37
+18
+95% +$937 ﹤0.01% 755
2026
Q1 		$911 Buy
19
+17
+850% +$745 ﹤0.01% 784
2025
Q4 		$77 Buy
+2
New +$76 ﹤0.01% 1098

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hughes Financial Services's RPRX Position: Q2 2026 in Review

Hughes Financial Services increased its Royalty Pharma (RPRX) stake by 95% in Q2 2026, buying an estimated $937 and bringing the position to 37 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Hughes Financial Services first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Hughes Financial Services held 37 shares of Royalty Pharma worth $2.08K as of Q2 2026.
  • Hughes Financial Services bought 18 Royalty Pharma shares in Q2 2026, an estimated $937.
  • Royalty Pharma made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #755 holding.
  • Hughes Financial Services first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.